Case number 2:23-cv-03372
Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 14, 2023 | 8 | Notice of Report on the filing of an action regarding a Patent or Trademark. (Attachments: # 1 Order Dismissing Case dated 7/5/2023) c/ecf (LC) (Entered: 08/14/2023) (0) |
| Jun 30, 2023 | 7 | NOTICE of Voluntary Dismissal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. without prejudice (Leonard, Jason) (Entered: 06/30/2023) (2) |
| May 4, 2023 | 1 | COMPLAINT against Ascent Pharmaceuticals, Inc. filing fee $ 402, receipt number ANYEDC-16666514 Was the Disclosure Statement on Civil Cover Sheet completed -YES,, filed by Astellas Pharma Inc., Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd.. (Attachments: # 1 Exhibit A -- U.S. Patent No. 10,842,780, # 2 Civil Cover Sheet, # 3 Civil Cover Sheet Attachment of Related Cases to Civil Cover Sheet, # 4 Proposed Summons to Ascent Pharmaceuticals, Inc.) (Leonard, Jason) (Entered: 05/04/2023) (0) |
| May 4, 2023 | 2 | This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (LJ) (Entered: 05/04/2023) (1) |
| May 4, 2023 | N/A | Case Assigned to Judge Joan M. Azrack and Magistrate Judge Steven Tiscione. Please download and review the Individual Practices of the assigned Judges, located on our website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (LJ) (Entered: 05/04/2023) (0) |
| May 4, 2023 | 3 | In accordance with Rule 73 of the Federal Rules of Civil Procedure and Local Rule 73.1, the parties are notified that if all parties consent a United States magistrate judge of this court is available to conduct all proceedings in this civil action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to the Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form may also be accessed at the following link: http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO085.pdf. You may withhold your consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. (LJ) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 4 | Notice of Report on the filing of an action regarding a Patent. (Attachments: # 1 Complaint, # 2 Exhibit A - U.S. Patent No. 10,842,780) (LJ) (Entered: 05/04/2023) (0) |
| May 4, 2023 | 5 | Summons Issued as to Ascent Pharmaceuticals, Inc. (LJ) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 6 | Corporate Disclosure Statement by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Other Affiliate Astellas B.V., Other Affiliate Astellas US Holding, Inc. for Astellas Pharma Inc.. (Leonard, Jason) (Entered: 05/04/2023) (2) |
